These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7902340)

  • 1. Screening of human bladder tumors and urine sediments for the presence of H-ras mutations.
    Levesque P; Ramchurren N; Saini K; Joyce A; Libertino J; Summerhayes IC
    Int J Cancer; 1993 Nov; 55(5):785-90. PubMed ID: 7902340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA; Williamson M
    Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PCR-RFLP method for the detection of activated H-ras oncogene with a point mutation at codon 12 and 61.
    Hong SJ; Lee T; Park YS; Lee KO; Chung BH; Lee SH
    Yonsei Med J; 1996 Dec; 37(6):371-9. PubMed ID: 9048488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors.
    Fitzgerald JM; Ramchurren N; Rieger K; Levesque P; Silverman M; Libertino JA; Summerhayes IC
    J Natl Cancer Inst; 1995 Jan; 87(2):129-33. PubMed ID: 7707384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice.
    Stanley LA; Devereux TR; Foley J; Lord PG; Maronpot RR; Orton TC; Anderson MW
    Carcinogenesis; 1992 Dec; 13(12):2427-33. PubMed ID: 1361883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras oncogene mutations in urine sediments of patients with bladder cancer.
    Buyru N; Tigli H; Ozcan F; Dalay N
    J Biochem Mol Biol; 2003 Jul; 36(4):399-402. PubMed ID: 12895299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of human bladder carcinomas for the presence of Ha-ras codon 12 mutation.
    Cattan N; Saison-Behmoaras T; Mari B; Mazeau C; Amiel JL; Rossi B; Gioanni J
    Oncol Rep; 2000; 7(3):497-500. PubMed ID: 10767358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas.
    Czerniak B; Cohen GL; Etkind P; Deitch D; Simmons H; Herz F; Koss LG
    Hum Pathol; 1992 Nov; 23(11):1199-204. PubMed ID: 1427748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.
    Devereux TR; Foley JF; Maronpot RR; Kari F; Anderson MW
    Carcinogenesis; 1993 May; 14(5):795-801. PubMed ID: 8504471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
    Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
    Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of H-ras mutations in human bladder cancer detected by direct sequencing.
    Burchill SA; Neal DE; Lunec J
    Br J Urol; 1994 May; 73(5):516-21. PubMed ID: 8012773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-ras activation and ras p21 expression in bladder tumors induced in F344/NCr rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Enomoto T; Ward JM; Perantoni AO
    Carcinogenesis; 1990 Dec; 11(12):2233-8. PubMed ID: 2265474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of N-ras gene mutations in medulloblastomas by polymerase chain reaction and oligonucleotide probes in formalin-fixed, paraffin-embedded tissues.
    Iolascon A; Lania A; Badiali M; Pession A; Saglio G; Giangaspero F; Miraglia del Giudice E; Perrotta S; Cutillo S
    Med Pediatr Oncol; 1991; 19(4):240-5. PubMed ID: 2056968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of H-ras gene point mutations in 50 cases of bladder carcinoma.
    Saito S; Hata M; Fukuyama R; Sakai K; Kudoh J; Tazaki H; Shimizu N
    Int J Urol; 1997 Mar; 4(2):178-85. PubMed ID: 9179693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of H-ras activation in naturally occurring hepatocellular tumors of C3H/HeNCr mice.
    Enomoto T; Weghorst CM; Ward JM; Anderson LM; Perantoni AO; Rice JM
    Carcinogenesis; 1993 Sep; 14(9):1939-44. PubMed ID: 8403222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of H-ras mutations in urine sediments by a mutant-enriched PCR technique.
    Conejo JR; Parra T; Cantero M; Jiménez A; Granizo V; de Arriba G; Carballo F
    Clin Chem; 1998 Jul; 44(7):1570-2. PubMed ID: 9665446
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
    Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple method to reveal possible ras mutations in DNA of urinary sediment cells.
    Cristaudo A; Vivaldi A; Guglielmi G; Sensales G; Ottenga F
    J Environ Pathol Toxicol Oncol; 1997; 16(2-3):201-4. PubMed ID: 9276002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.